AU2003244885A1 - Oral delivery of biological active agents in a nanoemulsion formulation to the human body - Google Patents
Oral delivery of biological active agents in a nanoemulsion formulation to the human bodyInfo
- Publication number
- AU2003244885A1 AU2003244885A1 AU2003244885A AU2003244885A AU2003244885A1 AU 2003244885 A1 AU2003244885 A1 AU 2003244885A1 AU 2003244885 A AU2003244885 A AU 2003244885A AU 2003244885 A AU2003244885 A AU 2003244885A AU 2003244885 A1 AU2003244885 A1 AU 2003244885A1
- Authority
- AU
- Australia
- Prior art keywords
- human body
- active agents
- oral delivery
- biological active
- nanoemulsion formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000013543 active substance Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000007908 nanoemulsion Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP0202032 | 2002-06-19 | ||
HU0202032A HUP0202032A2 (hu) | 2002-06-19 | 2002-06-19 | Nanoemulziós formulációban található bioaktív anyagok emberi szervezetbe való bevitele a szájüreg nyálkahártyáján keresztül, mechanikus pumpájú spray által. |
PCT/HU2003/000049 WO2004000274A1 (en) | 2002-06-19 | 2003-06-18 | Oral delivery of biological active agents in a nanoemulsion formulation to the human body |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003244885A1 true AU2003244885A1 (en) | 2004-01-06 |
Family
ID=89980533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003244885A Abandoned AU2003244885A1 (en) | 2002-06-19 | 2003-06-18 | Oral delivery of biological active agents in a nanoemulsion formulation to the human body |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU2003244885A1 (hu) |
GB (1) | GB0500594D0 (hu) |
HU (1) | HUP0202032A2 (hu) |
WO (1) | WO2004000274A1 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3988168B1 (ja) * | 2006-04-07 | 2007-10-10 | 伸司 嶋田 | イチョウ葉エキスナノ微粒子による脳細胞活性効果を有する組成物 |
JP5459939B2 (ja) * | 2006-06-09 | 2014-04-02 | 富士フイルム株式会社 | カロチノイド含有エマルジョン組成物、その製造方法、それを含む食品及び化粧品 |
CN101759727B (zh) * | 2009-09-30 | 2013-03-27 | 钱娟 | 一种纳米级松树皮提取物及其制备方法 |
US9289738B2 (en) * | 2009-12-15 | 2016-03-22 | Emultec S.R.L. | Nanoemulsion, method for its preparation and use |
US9468626B2 (en) | 2014-03-13 | 2016-10-18 | Chiesi Farmaceutici S.P.A. | Melatonin-based formulations for parenteral administration |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525341A (en) * | 1984-04-09 | 1985-06-25 | Mayor Pharmaceutical Laboratories, Inc. | Method of administering vitamins |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
US5891465A (en) * | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
FR2788007B1 (fr) * | 1999-01-05 | 2001-02-09 | Oreal | Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique |
FR2804014B1 (fr) * | 2000-01-21 | 2002-10-18 | Oreal | Nanoemulsion a base de lipides amphiphiles et de polymeres cationiques et utilisations |
FR2804016B1 (fr) * | 2000-01-21 | 2006-07-28 | Oreal | Nanoemulsion contenant des lipides amphiphiles et un ester de peg et utilisations |
JP4549625B2 (ja) * | 2002-01-05 | 2010-09-22 | 株式會社アモーレパシフィック | 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物 |
-
2002
- 2002-06-19 HU HU0202032A patent/HUP0202032A2/hu unknown
-
2003
- 2003-06-18 AU AU2003244885A patent/AU2003244885A1/en not_active Abandoned
- 2003-06-18 WO PCT/HU2003/000049 patent/WO2004000274A1/en not_active Application Discontinuation
-
2005
- 2005-01-12 GB GBGB0500594.7A patent/GB0500594D0/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
HUP0202032A2 (hu) | 2004-10-28 |
WO2004000274A1 (en) | 2003-12-31 |
HU0202032D0 (hu) | 2002-08-28 |
GB0500594D0 (en) | 2005-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003295614A1 (en) | Delivery of pharmaceutical agents via the human insulin receptor | |
AU2003264282A1 (en) | Phenethanolamine derivatives and their use in the treatment of respiratory diseases | |
DE60237199D1 (de) | Heilmittelzufuhr in den körper eines patienten | |
AU2003229084A1 (en) | Methods and formulations for the delivery of pharmacologically active agents | |
HK1066466A1 (en) | Pharmaceutical formulations of antineoplastic agents in particular temozolomide processes of making and using the same | |
AU2003210321A1 (en) | Use of sugar esters in cosmetic and/or pharmaceutical preparations | |
AU1200501A (en) | Drug delivery catheters that attach to tissue and methods for their use | |
AU2003280918A1 (en) | Rabbit skin comprising biological active substance and its use | |
GB0500594D0 (en) | Oral delivery of biological active agents in a nanoemulsion formulation to the human body | |
AU2003248153A1 (en) | Honey-based skin care preparation | |
EP1491210A4 (en) | THERAPEUTIC DRUG COMPRISING HOLLOW PROTEIN NANOPARTICLES HAVING HOLLOW PROTEIN ANTIBODIES AND NANOPARTICLES | |
AU2002224471A1 (en) | In vivo stimulation of angiogenic activity | |
AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
AU2002253785A1 (en) | Catheter and implants for the delivery of therapeutic agents to tissues | |
EP1583545A4 (en) | PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE | |
AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
AU2003234548A1 (en) | Solubilized formulations containing nylon suitable for personal care products | |
PL1663101T3 (pl) | Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie | |
AU2003235887A1 (en) | Bislactone derivative and use thereof in medicinal composition | |
AU2003286206A1 (en) | Use of a pear must extract as active principle in a cosmetic and/or pharmaceutical composition | |
AU2003275947A1 (en) | Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator | |
AU2003257624A1 (en) | Medical instrument to be implanted in the body | |
AU2003240446A1 (en) | Use of mob-5 in pain | |
AU2003244498A1 (en) | Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications | |
AU2003229656A1 (en) | A pharmaceutical formulation for endonasal administration and its use in the treatment of rhinitic symptoms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |